ANI Pharmaceuticals Inc (ANIP)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 428,530 | 457,599 | 338,540 | 358,740 | 195,700 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $428,530K)
= 0.00
The debt-to-capital ratio of ANI Pharmaceuticals Inc remained consistently at 0.00 over the five-year period from December 31, 2020, to December 31, 2024. This indicates that the company did not have any debt in its capital structure during this time frame. A debt-to-capital ratio of 0.00 typically suggests that the company relies entirely on equity financing rather than debt financing to fund its operations and investments. This may indicate a lower financial risk for the company as it does not have significant debt obligations to service. However, it is important to note that a very low or zero debt-to-capital ratio may also imply missed opportunities for leveraging debt for potential growth or tax benefits.
Peer comparison
Dec 31, 2024